Prosecution Insights
Prosecution Insights
7 pending office actions • 5 art units • 5 examiners • 0 of 7 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (14%) |
| §103 only | 2 (29%) |
| Double-patenting + other | 2 (29%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SKELDING, ZACHARY S | 3 | 59.8% | +41.0% |
| JOHNSON, CHRISTOPHER LINDSAY | 1 | 51.7% | +77.8% |
| BENAVIDES, JENNIFER ANN | 1 | 51.3% | +48.6% |
| O DELL, DAVID K | 1 | 57.7% | +36.0% |
| STONEBRAKER, ALYSSA RAE | 1 | 56.9% | +50.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18355871 | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation | SKELDING, ZACHARY S | 69d |
| 18290241 | VINYL ISOCYANIDE COMPOUNDS AS ANTIBACTERIAL AGENTS | JOHNSON, CHRISTOPHER LINDSAY | — |
| 17794214 | HDAC Degrader | O DELL, DAVID K | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18355871 | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation | SKELDING, ZACHARY S | 69d |
| 17498521 | Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria | STONEBRAKER, ALYSSA RAE | 76d |
| 18290241 | VINYL ISOCYANIDE COMPOUNDS AS ANTIBACTERIAL AGENTS | JOHNSON, CHRISTOPHER LINDSAY | — |
| 18474631 | METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION | SKELDING, ZACHARY S | — |
| 18312891 | METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION | SKELDING, ZACHARY S | — |
| 18051993 | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation | BENAVIDES, JENNIFER ANN | — |
| 17794214 | HDAC Degrader | O DELL, DAVID K | — |
| Art Unit | Apps |
|---|---|
| 1644 | 2 |
| 1691 | 1 |
| 1675 | 1 |
| 1621 | 1 |
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18290241 | VINYL ISOCYANIDE COMPOUNDS AS ANTIBACTERIAL AGENTS | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §101 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18474631 | METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION | SKELDING, ZACHARY S | — | §103 | Non-Final OA | — | Pending | Sep 26, 2023 |
| 18355871 | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation | SKELDING, ZACHARY S | 1644 | §102§103§112 | Non-Final OA | 69d | Pending | Jul 20, 2023 |
| 18312891 | METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION | SKELDING, ZACHARY S | 1644 | §103 | Non-Final OA | — | Pending | May 05, 2023 |
| 18051993 | Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation | BENAVIDES, JENNIFER ANN | 1675 | §103DP | Final Rejection | — | Pending | Nov 02, 2022 |
| 17794214 | HDAC Degrader | O DELL, DAVID K | 1621 | §103§112 | Final Rejection | — | Pending | Jul 20, 2022 |
| 17498521 | Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria | STONEBRAKER, ALYSSA RAE | 1642 | §112DPOther | Non-Final OA | 76d | Pending | Oct 11, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial